Science ❯ Biotechnology

Gene Editing

CRISPR Technology Therapeutic Applications Gene Therapy CRISPR CRISPR/Cas9 Base Editing Crispr Technology Therapeutics Xenotransplantation Research Chimeric Antigen Receptor Therapy Immune Regulation CRISPR Therapeutics In Vivo Therapy Research Therapeutic Technologies Therapeutic Gene Editing Xenotransplantation CRISPR Applications Crops AI in Medicine CRISPR-Cas9 Xenotransplants Animal Genomes Adeno-Associated Virus

Breakthrough T1D Backs CAR-Treg Beta-Cell Therapy as UChicago Reports PD‑L1 mRNA Results

Both efforts remain preclinical as teams focus on durability, delivery, dosing, safety, then translation to human testing.

FDA Proposes ‘Plausible Mechanism’ Pathway for Individualized Rare-Disease Therapies

Light-Based Sensor Detects Cancer Biomarkers in Blood at Sub-Attomolar Levels

EU Strikes Provisional Deal to Ease Rules for Gene-Edited Crops

CRISPR-Edited Fungus Boosts Mycoprotein Efficiency, Cuts Modeled Emissions

FDA Outlines 'Plausible-Mechanism' Pathway to Speed Bespoke Therapies

Intellia Pauses Phase 3 Trials of CRISPR Therapy After Severe Liver Event

Lilly to Buy Adverum in Gene‑Therapy Deal Worth Up to $12.47 a Share

Antibody Blocking SLAMF6 Restores T-Cell Attack on AML in Preclinical Study

Nature Papers Identify RHOG and CDKN1B as In Vivo Boosters for CAR T Cells

Kite Pharma to Buy Interius for $350 Million, Adding In‑Vivo CAR‑T Platform

Kidney Organoids Reveal NFκB‑Linked AAV2 Toxicity, With Bardoxolone Methyl Mitigating Damage

Prime Editing Reverses Rare Childhood Brain Disorder by Correcting Multiple Mutations in Mice

Single CRISPR Treatment Lets Mice Produce Weight-Loss Drug for Over Six Months

Personalized CRISPR Therapy Sends Baby KJ Home from CHOP

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors